Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine for postoperative analgesia in lumbar arthrodesis: plane block vs wound infiltration
2024-511406-23-00Phase 4Authorised
- Sponsor
- IRBLleida
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by IRBLleida. Primary endpoint: Morphine demand during the 48 hours after surgery. Planned start Nov 2025; status: authorised.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2024-511406-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511406-23-00.